Index
1 Market Overview
1.1 Product Overview and Scope of Developmental and Reproductive Toxicology (DART) Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Developmental and Reproductive Toxicology (DART) Services by Type
1.3.1 Overview: Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Developmental and Reproductive Toxicology (DART) Services Consumption Value Market Share by Type in 2022
1.3.3 Fertility and Early Embryonic Development (FEED) study
1.3.4 Embryofetal Development (EFD) study
1.3.5 Pre- and Post-natal (PPND) study
1.3.6 Others
1.4 Global Developmental and Reproductive Toxicology (DART) Services Market by Application
1.4.1 Overview: Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Biotechnology
1.4.3 Academic Research
1.4.4 Others
1.5 Global Developmental and Reproductive Toxicology (DART) Services Market Size & Forecast
1.6 Global Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast by Region
1.6.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region, (2018-2029)
1.6.3 North America Developmental and Reproductive Toxicology (DART) Services Market Size and Prospect (2018-2029)
1.6.4 Europe Developmental and Reproductive Toxicology (DART) Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size and Prospect (2018-2029)
1.6.6 South America Developmental and Reproductive Toxicology (DART) Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Developmental and Reproductive Toxicology (DART) Services Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Inotiv
2.1.1 Inotiv Details
2.1.2 Inotiv Major Business
2.1.3 Inotiv Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.1.4 Inotiv Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Inotiv Recent Developments and Future Plans
2.2 Accelera
2.2.1 Accelera Details
2.2.2 Accelera Major Business
2.2.3 Accelera Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.2.4 Accelera Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Accelera Recent Developments and Future Plans
2.3 Charles River
2.3.1 Charles River Details
2.3.2 Charles River Major Business
2.3.3 Charles River Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.3.4 Charles River Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Charles River Recent Developments and Future Plans
2.4 AnaPath Services
2.4.1 AnaPath Services Details
2.4.2 AnaPath Services Major Business
2.4.3 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.4.4 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AnaPath Services Recent Developments and Future Plans
2.5 Frontage
2.5.1 Frontage Details
2.5.2 Frontage Major Business
2.5.3 Frontage Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.5.4 Frontage Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Frontage Recent Developments and Future Plans
2.6 WuXi AppTec
2.6.1 WuXi AppTec Details
2.6.2 WuXi AppTec Major Business
2.6.3 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.6.4 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 WuXi AppTec Recent Developments and Future Plans
2.7 Creative Animodel
2.7.1 Creative Animodel Details
2.7.2 Creative Animodel Major Business
2.7.3 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.7.4 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Creative Animodel Recent Developments and Future Plans
2.8 Pharmaron
2.8.1 Pharmaron Details
2.8.2 Pharmaron Major Business
2.8.3 Pharmaron Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.8.4 Pharmaron Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pharmaron Recent Developments and Future Plans
2.9 Labcorp
2.9.1 Labcorp Details
2.9.2 Labcorp Major Business
2.9.3 Labcorp Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.9.4 Labcorp Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Labcorp Recent Developments and Future Plans
2.10 RCC
2.10.1 RCC Details
2.10.2 RCC Major Business
2.10.3 RCC Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.10.4 RCC Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 RCC Recent Developments and Future Plans
2.11 Creative Biolabs
2.11.1 Creative Biolabs Details
2.11.2 Creative Biolabs Major Business
2.11.3 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.11.4 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Creative Biolabs Recent Developments and Future Plans
2.12 IITRI
2.12.1 IITRI Details
2.12.2 IITRI Major Business
2.12.3 IITRI Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.12.4 IITRI Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 IITRI Recent Developments and Future Plans
2.13 Syngene
2.13.1 Syngene Details
2.13.2 Syngene Major Business
2.13.3 Syngene Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.13.4 Syngene Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Syngene Recent Developments and Future Plans
2.14 JOINN
2.14.1 JOINN Details
2.14.2 JOINN Major Business
2.14.3 JOINN Developmental and Reproductive Toxicology (DART) Services Product and Solutions
2.14.4 JOINN Developmental and Reproductive Toxicology (DART) Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 JOINN Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Developmental and Reproductive Toxicology (DART) Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Developmental and Reproductive Toxicology (DART) Services by Company Revenue
3.2.2 Top 3 Developmental and Reproductive Toxicology (DART) Services Players Market Share in 2022
3.2.3 Top 6 Developmental and Reproductive Toxicology (DART) Services Players Market Share in 2022
3.3 Developmental and Reproductive Toxicology (DART) Services Market: Overall Company Footprint Analysis
3.3.1 Developmental and Reproductive Toxicology (DART) Services Market: Region Footprint
3.3.2 Developmental and Reproductive Toxicology (DART) Services Market: Company Product Type Footprint
3.3.3 Developmental and Reproductive Toxicology (DART) Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Developmental and Reproductive Toxicology (DART) Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Developmental and Reproductive Toxicology (DART) Services Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Developmental and Reproductive Toxicology (DART) Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Developmental and Reproductive Toxicology (DART) Services Market Forecast by Application (2024-2029)
6 North America
6.1 North America Developmental and Reproductive Toxicology (DART) Services Consumption Value by Type (2018-2029)
6.2 North America Developmental and Reproductive Toxicology (DART) Services Consumption Value by Application (2018-2029)
6.3 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country
6.3.1 North America Developmental and Reproductive Toxicology (DART) Services Consumption Value by Country (2018-2029)
6.3.2 United States Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
6.3.3 Canada Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Developmental and Reproductive Toxicology (DART) Services Consumption Value by Type (2018-2029)
7.2 Europe Developmental and Reproductive Toxicology (DART) Services Consumption Value by Application (2018-2029)
7.3 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country
7.3.1 Europe Developmental and Reproductive Toxicology (DART) Services Consumption Value by Country (2018-2029)
7.3.2 Germany Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
7.3.3 France Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
7.3.5 Russia Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
7.3.6 Italy Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size by Region
8.3.1 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Consumption Value by Region (2018-2029)
8.3.2 China Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
8.3.3 Japan Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
8.3.5 India Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
8.3.7 Australia Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
9 South America
9.1 South America Developmental and Reproductive Toxicology (DART) Services Consumption Value by Type (2018-2029)
9.2 South America Developmental and Reproductive Toxicology (DART) Services Consumption Value by Application (2018-2029)
9.3 South America Developmental and Reproductive Toxicology (DART) Services Market Size by Country
9.3.1 South America Developmental and Reproductive Toxicology (DART) Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country
10.3.1 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
10.3.4 UAE Developmental and Reproductive Toxicology (DART) Services Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Developmental and Reproductive Toxicology (DART) Services Market Drivers
11.2 Developmental and Reproductive Toxicology (DART) Services Market Restraints
11.3 Developmental and Reproductive Toxicology (DART) Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Developmental and Reproductive Toxicology (DART) Services Industry Chain
12.2 Developmental and Reproductive Toxicology (DART) Services Upstream Analysis
12.3 Developmental and Reproductive Toxicology (DART) Services Midstream Analysis
12.4 Developmental and Reproductive Toxicology (DART) Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer